You are here: Industry Insights > Roche

News List

NICE u-turn backs Roche's Tecentriq for triple negative breast cancer pharmatimes
May 27, 2020
NICE is now backing NHS use of Tecentriq (atezolizumab) with nab-paclitaxel for treating PD L1-positive, triple-negative, advanced breast cancer, following an “improved offer” from drugmaker Roche.
Roche partners with Vividion on novel E3 Ligases pharmatimes
May 21, 2020
Roche has signed up for access to Vividion Therapeutics' proteomics screening platform and proprietary small molecule library to target E3 ligases and a range of oncology and immunology therapeutic targets.
Roche enters $135m drug discovery deal with Vividion Therapeutics pharmaceutical-technology
May 21, 2020
Roche has signed an exclusive worldwide option and licence agreement with US-based biotechnology firm Vividion Therapeutics to discover and develop small molecules for various therapeutic targets.
New US nod for Roche's Tecentriq in NSCLC pharmatimes
May 20, 2020
The US Food and Drug Administration has approved Roche's Tecentriq (atezolizumab) as a first-line treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression ...
Roche launches new blood gas digital solution pharmatimes
May 18, 2020
Roche has announced the launch Roche v-TAC, a new digital diagnostic solution that allows clinicians to get arterial blood gas values from patients with respiratory or metabolic abnormalities via a 'simpler ...
Roche Becomes Founding Partner in BaseLaunch contractpharma
May 18, 2020
Basel Area-based incubator that helps entrepreneurs launch biotech companies begins next phase of its company building activities.
NICE backs use of Roche's Gazyvaro with bendustamine pharmatimes
May 14, 2020
Patients with follicular lymphoma will now get NHS-funded treatment with Roche's Gazyvaro (binutuzumab)/bendamustine in England and Wales after cost regulators published guidelines backing its use in this setting.
UK’s NICE recommends Roche breast cancer drug Kadcyla pharmaceutical-technology
May 12, 2020
The National Institute for Health and Care Excellence (NICE) in the UK has recommended the use of Roche’s Kadcyla (trastuzumab emtansine) to treat certain patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.
US FDA gives EUA to Roche for COVID-19 antibody test expresspharma
May 05, 2020
The company aims to more than double production of tests from about 50 million a month to significantly more than 100 million a month by the end of the year.
FDA and EMA agree to review shorter infusion time of Roche’s Ocrevus pharmaceutical-technology
April 22, 2020
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have agreed to review Roche’s applications for a shorter infusion time of Ocrevus to treat relapsing or primary progressive multiple sclerosis (MS).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page